265 related articles for article (PubMed ID: 15857134)
1. Identification of novel low molecular weight CXCR4 antagonists by structural tuning of cyclic tetrapeptide scaffolds.
Tamamura H; Araki T; Ueda S; Wang Z; Oishi S; Esaka A; Trent JO; Nakashima H; Yamamoto N; Peiper SC; Otaka A; Fujii N
J Med Chem; 2005 May; 48(9):3280-9. PubMed ID: 15857134
[TBL] [Abstract][Full Text] [Related]
2. Structure-activity relationship study on artificial CXCR4 ligands possessing the cyclic pentapeptide scaffold: the exploration of amino acid residues of pentapeptides by substitutions of several aromatic amino acids.
Tanaka T; Nomura W; Narumi T; Esaka A; Oishi S; Ohashi N; Itotani K; Evans BJ; Wang ZX; Peiper SC; Fujii N; Tamamura H
Org Biomol Chem; 2009 Sep; 7(18):3805-9. PubMed ID: 19707686
[TBL] [Abstract][Full Text] [Related]
3. Structure-activity relationship study of CXCR4 antagonists bearing the cyclic pentapeptide scaffold: identification of the new pharmacophore.
Tanaka T; Tsutsumi H; Nomura W; Tanabe Y; Ohashi N; Esaka A; Ochiai C; Sato J; Itotani K; Murakami T; Ohba K; Yamamoto N; Fujii N; Tamamura H
Org Biomol Chem; 2008 Dec; 6(23):4374-7. PubMed ID: 19005596
[TBL] [Abstract][Full Text] [Related]
4. Structure-activity relationships of cyclic peptide-based chemokine receptor CXCR4 antagonists: disclosing the importance of side-chain and backbone functionalities.
Ueda S; Oishi S; Wang ZX; Araki T; Tamamura H; Cluzeau J; Ohno H; Kusano S; Nakashima H; Trent JO; Peiper SC; Fujii N
J Med Chem; 2007 Jan; 50(2):192-8. PubMed ID: 17228861
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological evaluation of selective CXCR4 antagonists containing alkene dipeptide isosteres.
Narumi T; Hayashi R; Tomita K; Kobayashi K; Tanahara N; Ohno H; Naito T; Kodama E; Matsuoka M; Oishi S; Fujii N
Org Biomol Chem; 2010 Feb; 8(3):616-21. PubMed ID: 20090978
[TBL] [Abstract][Full Text] [Related]
6. Structure-activity relationship studies on CXCR4 antagonists having cyclic pentapeptide scaffolds.
Tamamura H; Esaka A; Ogawa T; Araki T; Ueda S; Wang Z; Trent JO; Tsutsumi H; Masuno H; Nakashima H; Yamamoto N; Peiper SC; Otaka A; Fujii N
Org Biomol Chem; 2005 Dec; 3(24):4392-4. PubMed ID: 16327900
[TBL] [Abstract][Full Text] [Related]
7. Design and synthesis of all diastereomers of cyclic pseudo-dipeptides as mimics of cyclic CXCR4 pentapeptide antagonists.
Cluzeau J; Oishi S; Ohno H; Wang Z; Evans B; Peiper SC; Fujii N
Org Biomol Chem; 2007 Jun; 5(12):1915-23. PubMed ID: 17551641
[TBL] [Abstract][Full Text] [Related]
8. Stereoselective synthesis of [L-Arg-L/D-3-(2-naphthyl)alanine]-type (E)-alkene dipeptide isosteres and its application to the synthesis and biological evaluation of pseudopeptide analogues of the CXCR4 antagonist FC131.
Tamamura H; Hiramatsu K; Ueda S; Wang Z; Kusano S; Terakubo S; Trent JO; Peiper SC; Yamamoto N; Nakashima H; Otaka A; Fujii N
J Med Chem; 2005 Jan; 48(2):380-91. PubMed ID: 15658852
[TBL] [Abstract][Full Text] [Related]
9. Design of novel bicyclic analogues derived from a potent oxytocin antagonist.
Flouret G; Chaloin O; Borovickova L; Slaninová J
J Pept Sci; 2006 Jun; 12(6):412-9. PubMed ID: 16432806
[TBL] [Abstract][Full Text] [Related]
10. Roles of residues 3 and 4 in cyclic tetrapeptide ligand recognition by the kappa-opioid receptor.
Przydzial MJ; Pogozheva ID; Bosse KE; Andrews SM; Tharp TA; Traynor JR; Mosberg HI
J Pept Res; 2005 Mar; 65(3):333-42. PubMed ID: 15787963
[TBL] [Abstract][Full Text] [Related]
11. Structure-activity relationship study of a CXC chemokine receptor type 4 antagonist, FC131, using a series of alkene dipeptide isosteres.
Kobayashi K; Oishi S; Hayashi R; Tomita K; Kubo T; Tanahara N; Ohno H; Yoshikawa Y; Furuya T; Hoshino M; Fujii N
J Med Chem; 2012 Mar; 55(6):2746-57. PubMed ID: 22352868
[TBL] [Abstract][Full Text] [Related]
12. Novel sst5-selective somatostatin dicarba-analogues: synthesis and conformation-affinity relationships.
D'Addona D; Carotenuto A; Novellino E; Piccand V; Reubi JC; Di Cianni A; Gori F; Papini AM; Ginanneschi M
J Med Chem; 2008 Feb; 51(3):512-20. PubMed ID: 18210999
[TBL] [Abstract][Full Text] [Related]
13. Novel diastereomeric opioid tetrapeptides exhibit differing pharmacological activity profiles.
Ioja E; Tourwé D; Kertész I; Tóth G; Borsodi A; Benyhe S
Brain Res Bull; 2007 Sep; 74(1-3):119-29. PubMed ID: 17683797
[TBL] [Abstract][Full Text] [Related]
14. Highly potent cyclic disulfide antagonists of somatostatin.
Hocart SJ; Jain R; Murphy WA; Taylor JE; Coy DH
J Med Chem; 1999 Jun; 42(11):1863-71. PubMed ID: 10354394
[TBL] [Abstract][Full Text] [Related]
15. A minimalistic 3D pharmacophore model for cyclopentapeptide CXCR4 antagonists.
Våbenø J; Nikiforovich GV; Marshall GR
Biopolymers; 2006; 84(5):459-71. PubMed ID: 16552740
[TBL] [Abstract][Full Text] [Related]
16. A novel somatostatin mimic with broad somatotropin release inhibitory factor receptor binding and superior therapeutic potential.
Lewis I; Bauer W; Albert R; Chandramouli N; Pless J; Weckbecker G; Bruns C
J Med Chem; 2003 Jun; 46(12):2334-44. PubMed ID: 12773038
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, and biological evaluation of scaffold-based tripeptidomimetic antagonists for CXC chemokine receptor 4 (CXCR4).
Zachariassen ZG; Thiele S; Berg EA; Rasmussen P; Fossen T; Rosenkilde MM; Våbenø J; Haug BE
Bioorg Med Chem; 2014 Sep; 22(17):4759-69. PubMed ID: 25082513
[TBL] [Abstract][Full Text] [Related]
18. Disulfide cyclized tripeptide analogues of angiotensin IV as potent and selective inhibitors of insulin-regulated aminopeptidase (IRAP).
Andersson H; Demaegdt H; Vauquelin G; Lindeberg G; Karlén A; Hallberg M; Erdélyi M; Hallberg A
J Med Chem; 2010 Nov; 53(22):8059-71. PubMed ID: 21047126
[TBL] [Abstract][Full Text] [Related]
19. Topochemical exploration of potent compounds using retro-enantiomer libraries of cyclic pentapeptides.
Tamamura H; Mizumoto M; Hiramatsu K; Kusano S; Terakubo S; Yamamoto N; Trent JO; Wang Z; Peiper SC; Nakashima H; Otaka A; Fujii N
Org Biomol Chem; 2004 Apr; 2(8):1255-7. PubMed ID: 15064805
[TBL] [Abstract][Full Text] [Related]
20. Identification of novel non-peptide CXCR4 antagonists by ligand-based design approach.
Ueda S; Kato M; Inuki S; Ohno H; Evans B; Wang ZX; Peiper SC; Izumi K; Kodama E; Matsuoka M; Nagasawa H; Oishi S; Fujii N
Bioorg Med Chem Lett; 2008 Jul; 18(14):4124-9. PubMed ID: 18539453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
